Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
90.28 USD | +0.23% |
|
+0.68% | +16.45% |
07-02 | Goldman Sachs Adjusts Price Target on Nasdaq to $97 From $85, Maintains Buy Rating | MT |
07-01 | Nasdaq Beats NYSE in First-Half IPOs | MT |
Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 5.27 | 5.33 | 5.17 | 4.33 | 4 | |||||
Return on Total Capital | 7.7 | 8.09 | 8.56 | 6.8 | 5.84 | |||||
Return On Equity % | 15.45 | 18.49 | 17.87 | 12.44 | 10.12 | |||||
Return on Common Equity | 15.46 | 18.51 | 17.93 | 12.48 | 10.15 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 51.59 | 58.1 | 57.53 | 64.23 | 62.82 | |||||
SG&A Margin | 24.1 | 25.81 | 26.18 | 28.56 | 27.46 | |||||
EBITDA Margin % | 27.49 | 32.3 | 31.35 | 35.67 | 35.36 | |||||
EBITA Margin % | 25.73 | 30.46 | 29.67 | 33.74 | 33.68 | |||||
EBIT Margin % | 23.9 | 27.57 | 27.21 | 30.34 | 27.08 | |||||
Income From Continuing Operations Margin % | 16.58 | 20.17 | 18.04 | 17.43 | 15.07 | |||||
Net Income Margin % | 16.58 | 20.17 | 18.07 | 17.46 | 15.09 | |||||
Net Avail. For Common Margin % | 16.58 | 20.17 | 18.07 | 17.46 | 15.09 | |||||
Normalized Net Income Margin | 14.43 | 16.65 | 15.81 | 16.83 | 13.36 | |||||
Levered Free Cash Flow Margin | 16.39 | 16.84 | 22.36 | 21 | 23.77 | |||||
Unlevered Free Cash Flow Margin | 17.52 | 18.17 | 23.65 | 23.93 | 27.26 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.35 | 0.31 | 0.3 | 0.23 | 0.24 | |||||
Fixed Assets Turnover | 7.1 | 6.8 | 6.73 | 6.21 | 7.61 | |||||
Receivables Turnover (Average Receivables) | 11.39 | 10.15 | 9.83 | 7.5 | 7.55 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.56 | 0.94 | 0.97 | 1.01 | 0.99 | |||||
Quick Ratio | 0.68 | 0.13 | 0.14 | 0.16 | 0.21 | |||||
Operating Cash Flow to Current Liabilities | 0.25 | 0.14 | 0.19 | 0.19 | 0.25 | |||||
Days Sales Outstanding (Average Receivables) | 32.13 | 35.95 | 37.15 | 48.65 | 48.48 | |||||
Average Days Payable Outstanding | 21.7 | 26.64 | 25.54 | 43.5 | 39.98 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 92.85 | 97.63 | 95.8 | 100.98 | 88.6 | |||||
Total Debt / Total Capital | 48.15 | 49.4 | 48.93 | 50.24 | 46.98 | |||||
LT Debt/Equity | 92.14 | 81.16 | 84.15 | 97.72 | 84.54 | |||||
Long-Term Debt / Total Capital | 47.78 | 41.06 | 42.98 | 48.62 | 44.83 | |||||
Total Liabilities / Total Assets | 64.2 | 68.16 | 70.46 | 66.47 | 63.15 | |||||
EBIT / Interest Expense | 13.32 | 12.98 | 13.13 | 6.48 | 4.84 | |||||
EBITDA / Interest Expense | 16.38 | 16.08 | 15.94 | 8.07 | 6.59 | |||||
(EBITDA - Capex) / Interest Expense | 14.51 | 14.78 | 14.76 | 7.51 | 6.09 | |||||
Total Debt / EBITDA | 3.61 | 3.11 | 2.87 | 4.77 | 3.64 | |||||
Net Debt / EBITDA | 1.94 | 2.89 | 2.62 | 4.56 | 3.41 | |||||
Total Debt / (EBITDA - Capex) | 4.08 | 3.39 | 3.1 | 5.12 | 3.93 | |||||
Net Debt / (EBITDA - Capex) | 2.19 | 3.15 | 2.83 | 4.9 | 3.69 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 32.03 | 4.64 | 5.78 | -2.6 | 22.03 | |||||
Gross Profit, 1 Yr. Growth % | 14.52 | 17.81 | 4.74 | 8.74 | 19.36 | |||||
EBITDA, 1 Yr. Growth % | 16.58 | 22.88 | 2.68 | 10.81 | 20.99 | |||||
EBITA, 1 Yr. Growth % | 16.96 | 23.83 | 3.01 | 10.77 | 21.8 | |||||
EBIT, 1 Yr. Growth % | 18.29 | 20.67 | 4.37 | 8.62 | 8.91 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 20.54 | 27.22 | -5.39 | -5.88 | 5.49 | |||||
Net Income, 1 Yr. Growth % | 20.54 | 27.22 | -5.22 | -5.87 | 5.48 | |||||
Normalized Net Income, 1 Yr. Growth % | 20.17 | 20.71 | 0.46 | 3.81 | -3.12 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 20.73 | 26.12 | -3.83 | -7.96 | -7.21 | |||||
Accounts Receivable, 1 Yr. Growth % | 34.12 | 3.89 | 15.14 | 37.22 | 10.01 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 17.26 | 2.22 | 11.54 | 0.2 | -1.02 | |||||
Total Assets, 1 Yr. Growth % | 29.12 | 11.88 | 3.74 | 54.75 | -5.88 | |||||
Tangible Book Value, 1 Yr. Growth % | -10.22 | 81.55 | -6.64 | 137.12 | -9.95 | |||||
Common Equity, 1 Yr. Growth % | 14.08 | -0.59 | -3.82 | 75.84 | 3.47 | |||||
Cash From Operations, 1 Yr. Growth % | 30.01 | -13.5 | 57.53 | -0.59 | 14.33 | |||||
Capital Expenditures, 1 Yr. Growth % | 48.03 | -13.3 | -6.75 | 3.95 | 31.01 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 24.31 | 7.45 | 40.44 | -8.52 | 38.1 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 20.25 | 8.5 | 37.72 | -1.48 | 39.04 | |||||
Dividend Per Share, 1 Yr. Growth % | 4.86 | 8.75 | 11.43 | 10.26 | 9.3 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 14.7 | 17.57 | 5.21 | 1.5 | 9.02 | |||||
Gross Profit, 2 Yr. CAGR % | 7.2 | 16.15 | 11.08 | 6.72 | 13.92 | |||||
EBITDA, 2 Yr. CAGR % | 9.47 | 19.69 | 12.33 | 6.67 | 15.79 | |||||
EBITA, 2 Yr. CAGR % | 10.31 | 20.35 | 12.94 | 6.82 | 16.16 | |||||
EBIT, 2 Yr. CAGR % | 11.54 | 19.48 | 12.23 | 6.48 | 8.77 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 42.73 | 23.84 | 9.71 | -5.63 | -0.36 | |||||
Net Income, 2 Yr. CAGR % | 42.73 | 23.84 | 9.81 | -5.55 | -0.36 | |||||
Normalized Net Income, 2 Yr. CAGR % | 17.93 | 20.44 | 10.12 | 4.8 | 0.29 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 43.09 | 23.4 | 10.23 | -5.92 | -7.59 | |||||
Accounts Receivable, 2 Yr. CAGR % | 21.41 | 18.04 | 9.37 | 25.7 | 22.87 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 50.88 | 9.48 | 6.78 | 5.72 | -0.41 | |||||
Total Assets, 2 Yr. CAGR % | 7.01 | 20.19 | 7.74 | 26.71 | 20.69 | |||||
Tangible Book Value, 2 Yr. CAGR % | -8.82 | 27.67 | 30.19 | 48.79 | 46.13 | |||||
Common Equity, 2 Yr. CAGR % | 8.65 | 6.49 | -2.22 | 30.05 | 34.88 | |||||
Cash From Operations, 2 Yr. CAGR % | 10.36 | 6.05 | 16.73 | 25.14 | 6.61 | |||||
Capital Expenditures, 2 Yr. CAGR % | 30.14 | 13.29 | -10.08 | -1.55 | 16.7 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -5.17 | 15.57 | 22.84 | 13.35 | 12.4 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -6.17 | 14.22 | 22.24 | 16.48 | 17.04 | |||||
Dividend Per Share, 2 Yr. CAGR % | 6.83 | 6.79 | 9.54 | 10.84 | 9.78 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.54 | 11.23 | 13.5 | 2.54 | 7.93 | |||||
Gross Profit, 3 Yr. CAGR % | 6.39 | 10.63 | 12.21 | 10.29 | 10.78 | |||||
EBITDA, 3 Yr. CAGR % | 7.19 | 13.77 | 13.73 | 11.82 | 11.24 | |||||
EBITA, 3 Yr. CAGR % | 7.67 | 14.64 | 14.27 | 12.21 | 11.6 | |||||
EBIT, 3 Yr. CAGR % | 7.99 | 14.51 | 14.21 | 11.01 | 7.28 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 8.57 | 37.36 | 13.21 | 4.25 | -2.06 | |||||
Net Income, 3 Yr. CAGR % | 8.57 | 37.36 | 13.28 | 4.31 | -2.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | 12.35 | 18.85 | 13.37 | 7.93 | 2.09 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 9.14 | 37.2 | 13.56 | 3.8 | -6.35 | |||||
Accounts Receivable, 3 Yr. CAGR % | 16.71 | 15.26 | 17.06 | 17.96 | 20.23 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 28.87 | 32.52 | 10.16 | 4.54 | 3.42 | |||||
Total Assets, 3 Yr. CAGR % | 5.4 | 8.61 | 14.44 | 21.56 | 14.75 | |||||
Tangible Book Value, 3 Yr. CAGR % | -5.58 | 14.71 | 15.02 | 58.99 | 25.86 | |||||
Common Equity, 3 Yr. CAGR % | 3.04 | 5.48 | 2.94 | 18.91 | 20.51 | |||||
Cash From Operations, 3 Yr. CAGR % | 11.26 | 1.75 | 21 | 10.65 | 21.43 | |||||
Capital Expenditures, 3 Yr. CAGR % | 9.29 | 13.66 | 6.17 | -5.63 | 8.29 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 33.23 | -1.14 | 23.33 | 11.35 | 21.06 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 27.15 | -1.52 | 21.57 | 13.76 | 23.56 | |||||
Dividend Per Share, 3 Yr. CAGR % | 9.94 | 7.46 | 8.15 | 9.78 | 10.33 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 10.58 | 9.71 | 9.54 | 7.23 | 11.69 | |||||
Gross Profit, 5 Yr. CAGR % | 6.79 | 8.49 | 8.24 | 9.05 | 12.9 | |||||
EBITDA, 5 Yr. CAGR % | 7.71 | 10.42 | 9.22 | 10.87 | 14.55 | |||||
EBITA, 5 Yr. CAGR % | 7.88 | 10.88 | 9.75 | 11.45 | 15.02 | |||||
EBIT, 5 Yr. CAGR % | 7.68 | 10.44 | 9.67 | 11.22 | 12 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.92 | 62.12 | 9.03 | 18.21 | 7.57 | |||||
Net Income, 5 Yr. CAGR % | 16.87 | 62.12 | 9.06 | 18.25 | 7.61 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.81 | 13.62 | 11.45 | 11.82 | 7.92 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 17.46 | 62.1 | 9.54 | 17.98 | 4.57 | |||||
Accounts Receivable, 5 Yr. CAGR % | 12.36 | 6.51 | 13.72 | 19.33 | 19.35 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 21.52 | 19.31 | 19.53 | 21.07 | 5.81 | |||||
Total Assets, 5 Yr. CAGR % | 8.67 | 7.29 | 6.33 | 15.52 | 16.9 | |||||
Tangible Book Value, 5 Yr. CAGR % | 8.9 | 12.51 | 7.37 | 27.29 | 26.58 | |||||
Common Equity, 5 Yr. CAGR % | 2.78 | 3.33 | 0.91 | 14.7 | 14.69 | |||||
Cash From Operations, 5 Yr. CAGR % | 11.48 | 6.89 | 13.42 | 10.53 | 15.02 | |||||
Capital Expenditures, 5 Yr. CAGR % | 7.17 | 4 | 1.09 | 7.32 | 10.26 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.57 | 8.57 | 28.97 | 4.42 | 18.84 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 9.45 | 7.6 | 25.16 | 5.32 | 19.74 | |||||
Dividend Per Share, 5 Yr. CAGR % | 16.6 | 11.76 | 9.89 | 8.7 | 8.8 |
- Stock Market
- Equities
- NDAQ Stock
- Financials Nasdaq, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions

MarketScreener is also available in this country: United States.
Switch edition